MetaCap

Organigram Global Inc. (OGI)

NASDAQ: OGIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.583-0.0466 (-7.40%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

OGI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$82.27M
52-week range
0.583 – 2.24
Day range
0.583 – 0.6486
Volume / Avg
1.00M / 567.77K
Beta
—
Next earnings
Dec 15, 2026

52-week range

$0.583$2.24

OGI stock today

On Nov 20, OGI ended the session at $0.583, shedding $0.0466 (7.40%), versus the S&P 500's 3.70% decline. Shares are 74.0% below their 52-week high of $2.24, set on Dec 18, 2025 and 0.0% above the 52-week low of $0.583, near the bottom of the past year's range. OGI is down 65.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 60.6%.

Organigram Global trades at 1.4x its trailing twelve-month earnings per share of $0.43. Its forward P/E of 27.8x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. Organigram Global's next earnings report is expected on Dec 15, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Organigram Global

Company profile

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. James H. Yamanaka
Headquarters
Toronto, ON
Employees
1,139

Analyst forecast

Forecast

Consensus (4 analysts)

strong_buy

  • Strong buy 1
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Dec 15, 2026
EPS estimate
$0.02

OGI news

All OGI news

Organigram Global peers

Health Care sector
OGI peer companies
CompanyPrice% ChgMarket capCompare
HURATuHURA Biosciences Inc.1.25-8.09%$82.20Mvs OGI
NKTXNkarta Inc.1.14+1.34%$81.29Mvs OGI
ANIXAnixa Biosciences Inc.2.44-6.15%$84.82Mvs OGI
TLSATiziana Life Sciences Ltd.0.6206-8.14%$79.45Mvs OGI
UPBUpstream Bio Inc.1.59-20.50%$87.15Mvs OGI
EQEquillium Inc.1.06-5.36%$87.26Mvs OGI
RTSNRetension Pharmaceuticals Inc.10.51-19.22%$87.57Mvs OGI
CPIXCumberland Pharmaceuticals Inc.5.84-7.30%$87.57Mvs OGI

Indexes, lists and sector

Organigram Global stock FAQ

What is Organigram Global's stock price today?

OGI last traded at $0.583 as of Nov 20, 4:00 PM EST, down 7.40% on the day. Prices are delayed at least 15 minutes.

Does Organigram Global pay a dividend?

No. Organigram Global does not currently pay a regular cash dividend.

When is Organigram Global's next earnings date?

Organigram Global is expected to report earnings on Tuesday, December 15, 2026. Analysts expect EPS of $0.02.

What is OGI's P/E ratio?

OGI trades at a trailing P/E ratio of 1.36 and a forward P/E of 27.76.

Who is Organigram Global's CEO?

Mr. James H. Yamanaka is the chief executive officer of Organigram Global Inc., which has about 1,139 employees.

Has OGI ever split its stock?

Yes. The most recent OGI stock split was a 1-for-4 split on Jul 7, 2023.

What is the OGI 52-week high?

The 52-week high for OGI is $2.24 and the 52-week low is $0.583. The stock is currently 74.0% below its high.

Compare OGI